Elizabeth J Lilley1,2, John W Scott1,3, Joel S Weissman1, Anna Krasnova1, Ali Salim1,3, Adil H Haider1,3,4, Zara Cooper1,3. 1. The Center for Surgery and Public Health, Boston, Massachusetts. 2. Department of Surgery, Rutgers, Robert Wood Johnson Medical School, New Brunswick, New Jersey. 3. Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts. 4. Deputy Editor.
Abstract
Importance: More than 80% of older patients die or are seriously impaired within 1 year after severe traumatic brain injury (TBI). Given their poor survival, information about end-of-life care is a relevant marker of high-value trauma care for these patients. In-hospital mortality is commonly used to measure quality of trauma care; however, it is not known what type of end-of-life care hospitals with the best survival outcomes provide to those who die. Objective: To determine whether end-of-life care for older patients with TBI is correlated with in-hospital mortality. Design, Setting, and Participants: A retrospective cohort study using 2005-2011 national Medicare claims from acute care hospitals was conducted. Medicare beneficiaries aged 65 years or older who were admitted with serious or severe TBI were included. Transferred patients, those treated at low-volume hospitals, and those who died on the date of admission were excluded. Low-mortality hospitals were those in the lowest quartile for in-hospital mortality using standardized mortality rates adjusting for age, sex, race/ethnicity, comorbidity, and injury severity. Patients at low-mortality hospitals were compared with patients at all other hospitals. The study was conducted from January 2005 to December 2011. Data analysis was conducted between August 2016 and February 2017. Main Outcomes and Measures: End-of-life care outcomes for patients who died in hospital or 30 days or less after discharge included gastrostomy and tracheostomy placement during the TBI admission and enrollment in hospice. Results: Of 363 hospitals included in the analysis, 91 (25.1%) were designated as low-mortality. The cohort included 34 691 patients (median age, 79 years; interquartile range, 72-84 years; 40.8% women). Of these patients, 55.8% of those at low-mortality hospitals and 62.5% at all other hospitals died in the hospital or 30 days or less after discharge (P < .01). Among patients who died in the hospital (n = 16 994), end-of-life care was similar at low-mortality hospitals and all other hospitals. For patients who survived the TBI admission and died 30 days or less after discharge (n = 4027), those at low-mortality hospitals underwent fewer gastrostomy (15.9% vs 24.0%; adjusted OR, 0.61; 95% CI, 0.52-0.72) or tracheostomy (18.2% vs 24.9%; adjusted OR, 0.71; 95% CI, 0.60-0.83) procedures and received more hospice care (66.3% vs 52.5%; adjusted OR, 1.72; 95% CI, 1.50-1.96). Conclusions and Relevance: For older patients with serious or severe TBI, hospitals with the lowest in-hospital mortality perform fewer high-intensity treatments at the end of life and enroll more patients in hospice without increasing cumulative mortality 30 days or less after discharge.
Importance: More than 80% of older patients die or are seriously impaired within 1 year after severe traumatic brain injury (TBI). Given their poor survival, information about end-of-life care is a relevant marker of high-value trauma care for these patients. In-hospital mortality is commonly used to measure quality of trauma care; however, it is not known what type of end-of-life care hospitals with the best survival outcomes provide to those who die. Objective: To determine whether end-of-life care for older patients with TBI is correlated with in-hospital mortality. Design, Setting, and Participants: A retrospective cohort study using 2005-2011 national Medicare claims from acute care hospitals was conducted. Medicare beneficiaries aged 65 years or older who were admitted with serious or severe TBI were included. Transferred patients, those treated at low-volume hospitals, and those who died on the date of admission were excluded. Low-mortality hospitals were those in the lowest quartile for in-hospital mortality using standardized mortality rates adjusting for age, sex, race/ethnicity, comorbidity, and injury severity. Patients at low-mortality hospitals were compared with patients at all other hospitals. The study was conducted from January 2005 to December 2011. Data analysis was conducted between August 2016 and February 2017. Main Outcomes and Measures: End-of-life care outcomes for patients who died in hospital or 30 days or less after discharge included gastrostomy and tracheostomy placement during the TBI admission and enrollment in hospice. Results: Of 363 hospitals included in the analysis, 91 (25.1%) were designated as low-mortality. The cohort included 34 691 patients (median age, 79 years; interquartile range, 72-84 years; 40.8% women). Of these patients, 55.8% of those at low-mortality hospitals and 62.5% at all other hospitals died in the hospital or 30 days or less after discharge (P < .01). Among patients who died in the hospital (n = 16 994), end-of-life care was similar at low-mortality hospitals and all other hospitals. For patients who survived the TBI admission and died 30 days or less after discharge (n = 4027), those at low-mortality hospitals underwent fewer gastrostomy (15.9% vs 24.0%; adjusted OR, 0.61; 95% CI, 0.52-0.72) or tracheostomy (18.2% vs 24.9%; adjusted OR, 0.71; 95% CI, 0.60-0.83) procedures and received more hospice care (66.3% vs 52.5%; adjusted OR, 1.72; 95% CI, 1.50-1.96). Conclusions and Relevance: For older patients with serious or severe TBI, hospitals with the lowest in-hospital mortality perform fewer high-intensity treatments at the end of life and enroll more patients in hospice without increasing cumulative mortality 30 days or less after discharge.
Authors: David H Livingston; Robert F Lavery; Anne C Mosenthal; Margaret M Knudson; Seong Lee; Diane Morabito; Geoffrey T Manley; Avery Nathens; Gregory Jurkovich; David B Hoyt; Raul Coimbra Journal: J Trauma Date: 2005-12
Authors: Shahid Shafi; Avery B Nathens; H Gill Cryer; Mark R Hemmila; Michael D Pasquale; David E Clark; Melanie Neal; Sandra Goble; J Wayne Meredith; John J Fildes Journal: J Am Coll Surg Date: 2009-08-13 Impact factor: 6.113
Authors: J Matthew Austin; Ashish K Jha; Patrick S Romano; Sara J Singer; Timothy J Vogus; Robert M Wachter; Peter J Pronovost Journal: Health Aff (Millwood) Date: 2015-03 Impact factor: 6.301
Authors: Zain G Hashmi; Eric B Schneider; Renan Castillo; Elliott R Haut; Syed Nabeel Zafar; Edward E Cornwell; Ellen J Mackenzie; Asad Latif; Adil H Haider Journal: J Trauma Acute Care Surg Date: 2014-05 Impact factor: 3.313
Authors: James Forrest Calland; Angela M Ingraham; Niels Martin; Gary T Marshall; Carl I Schulman; Tristan Stapleton; Robert D Barraco Journal: J Trauma Acute Care Surg Date: 2012-11 Impact factor: 3.313
Authors: Elizabeth J Lilley; Katherine C Lee; John W Scott; Nicole J Krumrei; Adil H Haider; Ali Salim; Rajan Gupta; Zara Cooper Journal: J Trauma Acute Care Surg Date: 2018-11 Impact factor: 3.313
Authors: Alexis M Zebrowski; Jesse Y Hsu; Daniel N Holena; Douglas J Wiebe; Brendan G Carr Journal: J Trauma Acute Care Surg Date: 2022-01-01 Impact factor: 3.697
Authors: Jo Ellen Wilson; Myrick C Shinall; Taylor C Leath; Li Wang; Frank E Harrell; Laura D Wilson; Mina F Nordness; Shayan Rakhit; Michael R de Riesthal; Melissa C Duff; Pratik P Pandharipande; Mayur B Patel Journal: Ann Surg Date: 2021-03-01 Impact factor: 12.969
Authors: Flora M Hammond; Sheryl Katta-Charles; Mary Beth Russell; Ross D Zafonte; Jan Claassen; Amy K Wagner; Louis Puybasset; Satoshi Egawa; Steven Laureys; Michael Diringer; Robert D Stevens Journal: Neurocrit Care Date: 2021-07-08 Impact factor: 3.532
Authors: D Jochems; K J P van Wessem; R M Houwert; H B Brouwers; J W Dankbaar; M A van Es; M Geurts; A J C Slooter; L P H Leenen Journal: Crit Care Res Pract Date: 2018-09-23
Authors: Theresa Williamson; Marc D Ryser; Jihad Abdelgadir; Monica Lemmon; Mary Carol Barks; Rasheedat Zakare; Peter A Ubel Journal: PLoS One Date: 2020-03-02 Impact factor: 3.240